This is considered an important step forward in the treatment of dyslipidemia - a disease that progresses silently but is the main cause of myocardial infarction, stroke and many serious cardiovascular complications.
The new method using the active ingredient inclisiran, developed and produced by Novartis, has been approved by the Food and Drug Administration (FDA) since 2021. This approach allows for effective and sustainable reduction of bad cholesterol (LDL-C), requiring users to inject it only twice a year. (1) As of August 2024, the product has been approved in nearly 100 countries, including the United States, the EU, Japan, and China. (2)
FPT Long Chau pioneers in bringing new solutions in treatment for people with hyperlipidemia
Dyslipidemia, also known as lipid metabolism disorder, is a condition in which the amount of fat in the blood increases, affecting the circulation of blood in the blood vessel wall, leading to atherosclerosis. When atherosclerotic plaque is formed, the lumen of the blood vessel will be narrowed, obstructing blood flow, or even blood will not circulate. According to medical experts, dyslipidemia is one of the main causes of stroke. Dyslipidemia has been shown to be related to 56% of coronary artery disease and 18% of stroke. (3)
According to the Global Burden of Disease 2019, high blood fat caused nearly 4.4 million deaths, equivalent to 7.78% of deaths worldwide. (4) The Institute for Health Metrics and Evaluation (IHME) said that in Vietnam, an estimated 3.8 million people suffer from atherosclerotic cardiovascular disease, mainly caused by high blood fat (accounting for nearly 65%). (5) Given this situation, access to advanced treatment methods is urgent. A new generation solution with interference RNA (siRNA) technology helps patients achieve the goal of controlling blood fat, especially for patients recovering from myocardial infarction and stroke. (*)
The new solution not only helps expand effective treatment opportunities, reduce financial burdens but also raises awareness of disease prevention in the community.
Not only is this a step forward in the treatment of cardiovascular diseases caused by atherosclerosis and hyperlipidemia, this treatment direction is also a source of pride when Vietnamese people can access advanced treatment solutions right at home, at a more reasonable cost. This solution not only helps expand effective treatment opportunities, reduce financial burdens, but also raises awareness of disease prevention in the community, thereby creating positive changes in the journey of universal health care.
This is a consistent step in FPT Long Chau's strategy to develop a comprehensive healthcare ecosystem, with a commitment to not only providing high-quality genuine medicines but also accompanying patients long-term on their journey to healthy living.
FPT Long Chau's efforts in pioneering the introduction of high-quality products, new drugs, and rare drugs closer to the people to enhance risk control, support the treatment of chronic diseases, thereby contributing to improving public health. These steps also contribute to the country's common goal of building a civilized, modern healthcare system, approaching countries in the region and the world. Through that, FPT Long Chau continues to affirm its role as the "extended arm" of preventive medicine in Vietnam.
FPT Long Chau representative shared: "FPT Long Chau always identifies its role as a bridge to bring advanced medical solutions and world-leading healthcare methods closer to the Vietnamese people. We believe that every step forward in medicine is only truly meaningful when shared with as many people as possible. Therefore, we will continue to strive to update and deploy modern, safe, sustainable and practical treatment solutions for the community. This is FPT Long Chau's long-term commitment on the journey to fulfill the mission of taking care of Vietnamese people's health."
FPT Long Chau is a member of FPT Group. With the goal of providing practical services to serve the needs of community health care, the system with a network of more than 2,000 pharmacies and vaccination centers nationwide always upholds its mission and responsibility in helping people have the opportunity to access quality, genuine products at good prices and optimal services. Up to now, FPT Long Chau has been present in 63 provinces and districts nationwide, meeting the convenience of customers. People anywhere have the opportunity to access medicine and disease prevention services, advanced medical care closest to home, most conveniently.
(*) Patients can talk to their doctor for advice on new medical solutions.
Source: https://thanhnien.vn/fpt-long-chau-tien-phong-mang-giai-phap-moi-trong-dieu-tri-nguoi-bi-benh-mo-mau-185250409174827594.htm
Comment (0)